143 related articles for article (PubMed ID: 36512639)
1. RGD Peptide-Conjugated Dodecaborate with the Ga-DOTA Complex: A Preliminary Study for the Development of Theranostic Agents for Boron Neutron Capture Therapy and Its Companion Diagnostics.
Mishiro K; Imai S; Ematsu Y; Hirose K; Fuchigami T; Munekane M; Kinuya S; Ogawa K
J Med Chem; 2022 Dec; 65(24):16741-16753. PubMed ID: 36512639
[TBL] [Abstract][Full Text] [Related]
2. Cyclic RGD-Functionalized
Kawai K; Nishimura K; Okada S; Sato S; Suzuki M; Takata T; Nakamura H
Mol Pharm; 2020 Oct; 17(10):3740-3747. PubMed ID: 32845640
[TBL] [Abstract][Full Text] [Related]
3. Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy.
Kikuchi S; Kanoh D; Sato S; Sakurai Y; Suzuki M; Nakamura H
J Control Release; 2016 Sep; 237():160-7. PubMed ID: 27422608
[TBL] [Abstract][Full Text] [Related]
4. Development of a Gadolinium-Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy.
Okada S; Nishimura K; Ainaya Q; Shiraishi K; Anufriev SA; Sivaev IB; Sakurai Y; Suzuki M; Yokoyama M; Nakamura H
Mol Pharm; 2023 Dec; 20(12):6311-6318. PubMed ID: 37909734
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model.
Kashiwagi H; Kawabata S; Yoshimura K; Fukuo Y; Kanemitsu T; Takeuchi K; Hiramatsu R; Nishimura K; Kawai K; Takata T; Tanaka H; Watanabe T; Suzuki M; Miyatake SI; Nakamura H; Wanibuchi M
Invest New Drugs; 2022 Apr; 40(2):255-264. PubMed ID: 34816337
[TBL] [Abstract][Full Text] [Related]
6. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
[TBL] [Abstract][Full Text] [Related]
7. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
[TBL] [Abstract][Full Text] [Related]
8. Iodophenyl-conjugated closo-dodecaborate as a promising small boron molecule that binds to serum albumin and accumulates in tumor.
Nishimura K; Harrison S; Kawai K; Morita T; Miura K; Okada S; Nakamura H
Bioorg Med Chem Lett; 2022 Sep; 72():128869. PubMed ID: 35772634
[TBL] [Abstract][Full Text] [Related]
9. Tumor Cell-Specific 2'-Fluoro RNA Aptamer Conjugated with
Vorobyeva MA; Dymova MA; Novopashina DS; Kuligina EV; Timoshenko VV; Kolesnikov IA; Taskaev SY; Richter VA; Venyaminova AG
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298946
[TBL] [Abstract][Full Text] [Related]
10. Homocystamide Conjugates of Human Serum Albumin as a Platform to Prepare Bimodal Multidrug Delivery Systems for Boron Neutron Capture Therapy.
Popova T; Dymova MA; Koroleva LS; Zakharova OD; Lisitskiy VA; Raskolupova VI; Sycheva T; Taskaev S; Silnikov VN; Godovikova TS
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770947
[TBL] [Abstract][Full Text] [Related]
11. Water-Soluble
Nakagawa F; Kawashima H; Morita T; Nakamura H
Cells; 2020 Jul; 9(7):. PubMed ID: 32635272
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of (10)B for Boron Neutron Capture Therapy (BNCT) in a mouse model after injection of sodium mercaptoundecahydro-closo-dodecaborate and l-para-boronophenylalanine.
Wittig A; Huiskamp R; Moss RL; Bet P; Kriegeskotte C; Scherag A; Hilken G; Sauerwein WA
Radiat Res; 2009 Oct; 172(4):493-9. PubMed ID: 19772470
[TBL] [Abstract][Full Text] [Related]
13. Design of the New
Raskolupova VI; Wang M; Dymova MA; Petrov GO; Shchudlo IM; Taskaev SY; Abramova TV; Godovikova TS; Silnikov VN; Popova TV
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985644
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H
Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274
[TBL] [Abstract][Full Text] [Related]
15. Boron Neutron Capture Therapy (BNCT) Mediated by Maleimide-Functionalized
Monti Hughes A; Goldfinger JA; Palmieri MA; Ramos P; Santa Cruz IS; De Leo L; Garabalino MA; Thorp SI; Curotto P; Pozzi ECC; Kawai K; Sato S; Itoiz ME; Trivillin VA; Guidobono JS; Nakamura H; Schwint AE
Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888170
[TBL] [Abstract][Full Text] [Related]
16. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.
Wang S; Blaha C; Santos R; Huynh T; Hayes TR; Beckford-Vera DR; Blecha JE; Hong AS; Fogarty M; Hope TA; Raleigh DR; Wilson DM; Evans MJ; VanBrocklin HF; Ozawa T; Flavell RR
Mol Pharm; 2019 Sep; 16(9):3831-3841. PubMed ID: 31381351
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of new BSH-conjugated chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.
Asano R; Nagami A; Fukumoto Y; Miura K; Yazama F; Ito H; Sakata I; Tai A
J Photochem Photobiol B; 2014 Nov; 140():140-9. PubMed ID: 25123528
[TBL] [Abstract][Full Text] [Related]
19. Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT).
Wu CY; Lin JJ; Chang WY; Hsieh CY; Wu CC; Chen HS; Hsu HJ; Yang AS; Hsu MH; Kuo WY
Colloids Surf B Biointerfaces; 2019 Nov; 183():110387. PubMed ID: 31394419
[TBL] [Abstract][Full Text] [Related]
20. Closo-dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistribution.
Tolmachev V; Koziorowski J; Sivaev I; Lundqvist H; Carlsson J; Orlova A; Gedda L; Olsson P; Sjöberg S; Sundin A
Bioconjug Chem; 1999; 10(3):338-45. PubMed ID: 10346862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
